INTERLEUKIN GENETICS INC·4

Jan 3, 6:35 PM ET

Snyder Scott A. 4

4 · INTERLEUKIN GENETICS INC · Filed Jan 3, 2013

Insider Transaction Report

Form 4
Period: 2013-01-02
Snyder Scott A.
Chief Marketing Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2013-01-02+200,000200,000 total
    Exercise: $0.29Exp: 2023-01-02Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on 01/02/2013, which was the grant date of the option.
  • [F2]The option vests as to 50,000, 66,000 and 84,000 shares on the first, second and third anniversaries of the grant date, respectively.

Documents

1 file
  • 4
    v331378_form4.xmlPrimary

    OWNERSHIP DOCUMENT